Stock REDW REDWOOD PHARMA AB
Add to a list
To use this feature you must be a member
Log inSign up

All News Redwood Pharma AB

Equities

REDW

SE0021512134

Delayed Nasdaq Stockholm
Other stock markets
 11:02:32 2024-06-20 EDT 		5-day change 1st Jan Change
2.9 SEK -16.43% Intraday chart for Redwood Pharma AB +262.65% -35.96%
06-12 Redwood Pharma Provides an Update on the Process for Divesting the Company's Assets CI
05-23 Redwood Pharma Provides Update on Process to Divest Assets CI

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Redwood Pharma provides an update on the process for divesting the company's assets
AQ
Redwood Pharma Provides an Update on the Process for Divesting the Company's Assets
CI
Redwood Pharma provides an update on the company's future
AQ
Redwood Pharma Provides Update on Process to Divest Assets
CI
Redwood Pharma's product RP501 attracted a lot of interest at ARVO in Seattle
AQ
Redwood Pharma AB's Product RP501 attracted a lot of interest at ARVO in Seattle
CI
Two international companies begin due diligence on Redwood Pharma's product RP501 ahead of potential commercial agreements
AQ
Two International Companies Begin Due Diligence on Redwood Pharma AB's Product RP501 Ahead of Potential Commercial Agreements
CI
Redwood Pharma's board subscribes to units in the ongoing new issue
AQ
Redwood Pharma AB Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Redwood Pharma's innovative dry eye treatment to be presented at ARVO in Seattle
AQ
Redwood Pharma AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023
CI
Redwood Pharma's CEO Martin Vidaeus in year-end interview
AQ
Redwood Pharma to participate in the JP Morgan Healthcare Conference
AQ
Redwood Pharma AB (publ) changes Certified Adviser to Carnegie Investment Bank AB (publ)
AQ
Redwood Pharma AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Redwood Pharma to participate in the NLS Days partner conference in Copenhagen
AQ
Redwood Pharma to participate in the BIO-Europe partnering conference in Munich
AQ
Redwood Pharma AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
Redwood Pharma presents positive results from a clinical study with RP501 against dry eye
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. REDW Stock
  4. News Redwood Pharma AB